Ibrutinib impurity 6(1987905-93-0)
- Name: Ibrutinib impurity 6
- Synonyms:Ibrutinib impurity 6;1987905-93-0;ZPJ4HT8UNA;UNII-ZPJ4HT8UNA;1-Propanone, 1,3-bis((3R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo(3,4-d)pyrimidin-1-yl)-1-piperidinyl)-;1,3-Bis((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one (Imatinib Impurity);1,3-bis[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]propan-1-one;3-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-1-[(3R)-3-[4-imino-3-(4-phenoxyphenyl)-1H,2H,4H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]propan-1-one;1,3-bis((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-piperidin-1-yl)propan-1-one;CS-0167020;F82872;EN300-1726129;Z3186055548;1,3-Bis((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one? (Imatinib Impurity
- Molecular Formula:C47H46N12O3
- Molecular Weight:826.9
- CAS Registry Number:1987905-93-0
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1987905-93-0 Ibrutinib Impurity 6
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Transportation:express and sea transport and air freight Application:for drug impurity for drug standards,for drug research and development銆侱rug impurity reference, drug standard, analytical chemistry, standard substance, organic chemical synthesis, chemical custo...
Min. Order:25Milligram
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)]
CAS No.1987905-93-0 1,3-bis((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-piperidin-1-yl)propan-1-one
Assay:鈮?5% Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]

Other Product
- 1619991-11-5/3-(Difluoromethoxy)azetidine hydrochloride
- 1082040-29-6/4-Methoxypiperidine-4-carboxylic acid
- 1220019-84-0/Methyl 4-[(3-piperidinyloxy)methyl]benzoate hydrochloride
- 308266-10-6/2-phenylmethoxy-N,N-bis(phenylmethyl)acetamide
- 1286274-22-3/N-Ethyl-N-(piperidin-4-yl)propionamide hydrochloride
- 1196152-22-3/6-Chloro-4-hydroxynicotinaldehyde
- 1451392-91-8/(3,4-Difluoro-2-formylphenyl)boronic acid
- 1219979-45-9/4-[2-(3-Piperidinyl)ethyl]morpholine
- 1242267-89-5/tert-Butyl 4-[2-(hydrazinecarbonyl)-4-nitrophenyl]piperazine-1-carboxylate
- 1206122-86-2/1-(1H-tetrazol-1-yl)cyclohexanecarboxylic acid
- 21877-94-1/Sulfuric acid--3-({4-[4-(2,4-diamino-6-methylpyrimidin-5-yl)butyl]phenyl}carbamoyl)benzene-1-sulfonyl fluoride (1/1)
- 2167346-89-4/1-(Bicyclo[1.1.1]pentan-1-yl)piperazine
- 1220033-93-1/3-{2-[2-Bromo-4-(tert-pentyl)phenoxy]-ethyl}piperidine hydrochloride
- 1286275-65-7/tert-Butyl (1R*,4R*)-4-(3-bromobenzylamino)-cyclohexylcarbamate
- 873054-45-6/N-(2,5-dimethylphenyl)-4-oxo-1H-quinoline-3-carboxamide
- 942206-34-0/4,6-Di(pyridin-3-yl)pyrimidine
- 3645-96-3/Isobutyl ricinoleate
- 614752-51-1/6-Chloro-4-fluoropicolinaldehyde
- 7468-92-0/3-Bromobenzo[a]phenazin-5-ol
- 1987905-93-0/Ibrutinib impurity 6
- 1491158-71-4/Fmoc-D-Lys(Pal-Glu-OtBu)-OH
- 117121-51-4/N'-[3-Chloro-4-[(2-ethyl-2H-tetrazole-5-yl)oxy]phenyl]-N,N-dimethylurea
- 1219967-89-1/N,N-Diethyl-3-[2-(4-piperidinyl)ethoxy]aniline hydrochloride
- 941282-94-6/4-(2-Hydroxyethoxy)-3,4-dimethylcyclohexa-2,5-dien-1-one
- 1233955-67-3/tert-Butyl 4-[(2-amino-6-fluorophenylamino)methyl]piperidine-1-carboxylate
- 1261618-73-8/Methyl 2-(2-amino-5-bromophenyl)acetate
- 5431-57-2/Phosphoric acid--N~4~-(5-chloroisoquinolin-1-yl)-N~1~,N~1~-diethylpentane-1,4-diamine (1/1)
- 1000573-09-0/1,4-Dibromo-2-chloro-3-fluorobenzene
- 294865-05-7/7,11-Imino-2H-pyrazino(1,2-a)azocine-3,6(4H,7H)-dione, 2-(3,5-dimethoxyphenyl)-12-((3,5-dimethoxyphenyl)oxoacetyl)-8,9,10,11-tetrahydro-
- 75417-40-2/2,12-Dimethyl-3,7,11,17-tetrazanidabicyclo[11.3.1]heptadecane;nickel(2+);perchloric acid